Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Michael Thomas exercised options for 3,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 20, 2026

On Apr 16, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) exercised options for 3,000 Apogee Therapeutics, Inc. shares at US$22.86 for US$68,580, leaving 1,135,987 shares. Filed Apr 20, 2026 (Form 4).

Options exercised
3,000 shares
Price
US$22.86
Value
US$68,580
Holding after
1,135,987 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockOption exercise3,000US$22.861,135,987Direct

Source

View original at SEC

Related